Invictus RG’s PetMed Express PETS Stock Holding History

Invictus RG’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,612	Closed	-$53K	–	437
2017 Q3	$53K	Buy	+1,612	New	+$65.6K	0.05%	365

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invictus RG's PETS Position: Q4 2017 in Review

Invictus RG sold out of PetMed Express (PETS) in Q4 2017, closing a stake of 1,612 shares — an estimated $53K sold.

Invictus RG first reported a position in PETS in Q3 2017 and held it in 1 quarter. The position peaked at $53K in Q3 2017. 194 funds tracked by Wall St. Rank hold PETS as of Q4 2017.

Invictus RG reported no remaining PetMed Express position as of Q4 2017 after selling out during the quarter.
Invictus RG sold 1,612 PetMed Express shares in Q4 2017, an estimated $53K.
Invictus RG first reported a position in PetMed Express in Q3 2017 and held it in 1 quarter.
Invictus RG's PetMed Express position peaked at $53K in Q3 2017.
194 funds tracked by Wall St. Rank held PetMed Express as of Q4 2017.

Based on Invictus RG's 13F filing for Q4 2017, filed 13 Feb 2018.